Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo

Bispyrene-Based Self-Assembled Nanomaterials: In Vivo Self-Assembly, Transformation, and Biomedical Effects

(2019) Ping-Ping He et al.   ACCOUNTS OF CHEMICAL RESEARCH

Self-Assembled Peptide-Based Nanomaterials for Biomedical Imaging and Therapy

(2018) Guo-Bin Qi et al.   ADVANCED MATERIALS

Enzymatic Reaction Selects Secondary Structures of Heterotypic Supramolecular Assemblies of Peptides

(2018) Jie Li et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Cooperativity Principles in Self-Assembled Nanomedicine

(2018) Yang Li et al.   CHEMICAL REVIEWS

Targeting HER2 by Combination Therapies

(2018) Ana Ruiz-Saenz et al.   JOURNAL OF CLINICAL ONCOLOGY

Self-Assembling Ability Determines the Activity of Enzyme-Instructed Self-Assembly for Inhibiting Cancer Cells

(2017) Zhaoqianqi Feng et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Liquid phase condensation in cell physiology and disease

(2017) Yongdae Shin et al.   SCIENCE

Mitochondria localization induced self-assembly of peptide amphiphiles for cellular dysfunction

(2017) M. T. Jeena et al.   Nature Communications

Thermo-Controlled in Situ Phase Transition of Polymer–Peptides on Cell Surfaces for High-Performance Proliferative Inhibition

(2016) Sheng-Lin Qiao et al.   ACS Applied Materials & Interfaces

Ligand–Receptor Interaction Modulates the Energy Landscape of Enzyme-Instructed Self-Assembly of Small Molecules

(2016) Richard Haburcak et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Supramolecular biomaterials

(2016) Matthew J. Webber et al.   NATURE MATERIALS

Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize

(2016) Stephen R. Adams et al.   Nature Communications

Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors

(2016) Wenwu Xiao et al.   EJNMMI Research

In Situ Formation of Nanofibers from Purpurin18-Peptide Conjugates and the Assembly Induced Retention Effect in Tumor Sites

(2015) Di Zhang et al.   ADVANCED MATERIALS

Proteomics discovery of radioresistant cancer biomarkers for radiotherapy

(2015) Lei Chang et al.   CANCER LETTERS

Cancer Cell Death Induced by the Intracellular Self-Assembly of an Enzyme-Responsive Supramolecular Gelator

(2015) Akiko Tanaka et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Controlling Cancer Cell Fate Using Localized Biocatalytic Self-Assembly of an Aromatic Carbohydrate Amphiphile

(2015) Ricardo A. Pires et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Supramolecular systems chemistry

(2015) Elio Mattia et al.   Nature Nanotechnology

Breast cancer therapy-associated cardiovascular disease

(2015) Timothy M. Zagar et al.   Nature Reviews Clinical Oncology

Pericellular Hydrogel/Nanonets Inhibit Cancer Cells

(2014) Yi Kuang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1 -mediated glucose metabolism

(2013) H.-J. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

(2012) N. Duru et al.   CLINICAL CANCER RESEARCH

Pathway complexity in supramolecular polymerization

(2012) Peter A. Korevaar et al.   NATURE

Treatment of HER2-positive breast cancer: current status and future perspectives

(2011) Carlos L. Arteaga et al.   Nature Reviews Clinical Oncology

Molecular circuits of solid tumors: prognostic and predictive tools for bedside use

(2010) Charles Ferté et al.   Nature Reviews Clinical Oncology

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

(2008) C. Gravalos et al.   ANNALS OF ONCOLOGY

Structure-Based View of Epidermal Growth Factor Receptor Regulation

(2008) Kathryn M. Ferguson   Annual Review of Biophysics

Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer

(2008) Gabriella Mariani et al.   Nature clinical practice. Oncology

Therapy Insight: anthracyclines and trastuzumab—the optimal management of cardiotoxic side effects

(2008) Sanjay Popat et al.   Nature clinical practice. Oncology